methylprednisolone has been researched along with captopril in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (25.00) | 18.7374 |
| 1990's | 1 (5.00) | 18.2507 |
| 2000's | 7 (35.00) | 29.6817 |
| 2010's | 7 (35.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Del Pizzo, R; Gauthier, B; Trachtman, H; Valderrama, E | 1 |
| Boyce, NW; Holdsworth, SR | 1 |
| Iwata, H; Ochi, K; Takeuchi, M; Yokoyama, M | 1 |
| Ahonen, J; Fyhrquist, F; Grönhagen-Riska, C; Häyry, P; von Willebrand, E | 1 |
| Franco, RJ; Kohlmann, O; Marson, O; Ramos, OL; Ribeiro, AB | 1 |
| Elijovich, F; Krakoff, LR | 1 |
| Saxena, PR; Schoemaker, RG; Van Kerckhoven, R; van Veghel, R | 1 |
| El-Ashmawy, NE; El-Bahrawy, HA; Hamada, OB; Khedr, NF | 1 |
1 review(s) available for methylprednisolone and captopril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
19 other study(ies) available for methylprednisolone and captopril
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
The renal functional and structural consequences of corticosteroid and angiotensin-converting enzyme inhibitor therapy in chronic puromycin aminonucleoside nephropathy.
Topics: Adrenal Cortex Hormones; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Disease Models, Animal; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Kidney Failure, Chronic; Male; Methylprednisolone; Nephrotic Syndrome; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains | 1990 |
Intrarenal hemodynamic alterations induced by anti-GBM antibody.
Topics: Animals; Antibodies; Autoantibodies; Basement Membrane; Captopril; Creatinine; Glomerular Filtration Rate; Indomethacin; Kidney; Kidney Glomerulus; Methylprednisolone; Perfusion; Promethazine; Rats; Renal Circulation; Renin; Saralasin; Sodium; Vascular Resistance | 1987 |
Pharmacological enhancement of recovery in experimental hydronephrosis.
Topics: Animals; Captopril; Furosemide; Hydronephrosis; Indomethacin; Inosine; Kidney; Kidney Cortex; Kidney Medulla; Male; Mannitol; Methylprednisolone; Rats; Rats, Inbred Strains | 1985 |
Angiotensin I-converting enzyme inhibition after renal transplantation.
Topics: Adult; Agranulocytosis; Angiotensin-Converting Enzyme Inhibitors; Azathioprine; Blood Pressure; Captopril; Female; Graft Rejection; Graft Survival; Humans; Kidney Function Tests; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Proline; Random Allocation | 1984 |
Etiopathogenesis of excess methylprednisolone arterial hypertension in the rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Captopril; Disease Models, Animal; Hypertension; Male; Methylprednisolone; Rats; Rats, Inbred Strains; Renin-Angiotensin System; Saralasin | 1981 |
Mechanism of the response to captopril in glucocorticoid hypertension.
Topics: Animals; Blood Pressure; Body Weight; Captopril; Female; Hypertension; Lung; Methylprednisolone; Peptidyl-Dipeptidase A; Proline; Rats; Rats, Inbred Strains; Renin; Sodium | 1982 |
Pharmacological therapy can increase capillary density in post-infarction remodeled rat hearts.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aspirin; Blood Pressure; Capillaries; Captopril; Coronary Circulation; Glucocorticoids; Heart Rate; Hypertrophy, Left Ventricular; Imidazoles; Male; Methylprednisolone; Myocardial Infarction; Neovascularization, Physiologic; Random Allocation; Rats; Rats, Wistar; Sympatholytics | 2004 |
Anti-inflammatory and Antioxidant Effects of Captopril Compared to Methylprednisolone in L-Arginine-Induced Acute Pancreatitis.
Topics: Acute Disease; alpha-Amylases; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents; Antioxidants; Arginine; Captopril; Cytoprotection; Disease Models, Animal; Glutathione; Lipase; Male; Methylprednisolone; Nitric Oxide; Nitric Oxide Synthase Type II; Pancreas; Pancreatitis; Peroxidase; Rats, Wistar; Renin-Angiotensin System; Signal Transduction; Tumor Necrosis Factor-alpha | 2018 |